Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 03, 2015 07:00 ET | Source: Emergent Biosolutions, Inc.

Emergent BioSolutions Expands Biodefense Business Through Launch of a Military-Grade Auto-Injector Device for Chemical Threats

GAITHERSBURG, Md., Aug. 3, 2015 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced that it is launching a ruggedized, military-grade auto-injector device, known as...
July 23, 2015 07:00 ET | Source: Emergent Biosolutions, Inc.

Emergent BioSolutions to Release Second Quarter 2015 Financial Results and Conduct a Conference Call on August 6, 2015

GAITHERSBURG, Md., July 23, 2015 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) will host a conference call on Thursday, August 6, 2015 at 8:00 am (Eastern Time) to discuss the financial...
July 20, 2015 07:00 ET | Source: Emergent Biosolutions, Inc.

Emergent BioSolutions Awarded $19.7 Million BARDA Contract to Develop and Manufacture Ebola Monoclonal Antibodies

GAITHERSBURG, Md., July 20, 2015 (GLOBE NEWSWIRE) -- Emergent BioSolutions (NYSE:EBS) today announced that it has been awarded a contract by the Biomedical Advanced Research and Development Authority...
May 19, 2015 07:00 ET | Source: Emergent Biosolutions, Inc.

Emergent BioSolutions Signs Long-Term Manufacturing Agreement With Prometic Life Sciences

GAITHERSBURG, Md., May 19, 2015 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced that it has signed a strategic long-term manufacturing agreement with ProMetic Life Sciences...
May 14, 2015 07:00 ET | Source: Emergent Biosolutions, Inc.

Emergent BioSolutions to Hold Annual Meeting of Stockholders Thursday May 21, 2015 at 9:00 AM Eastern; Webcast Will be Available

GAITHERSBURG, Md., May 14, 2015 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) has announced that it will hold its Annual Meeting of Stockholders on Thursday, May 21, 2015 beginning at 9:00...
May 13, 2015 07:00 ET | Source: Emergent Biosolutions, Inc.

Oxford University, GSK, and Emergent BioSolutions Announce Initiation of a Prime Boost Study of Ebola Vaccine Candidates

OXFORD, U.K., LONDON and GAITHERSBURG, Md., May 13, 2015 (GLOBE NEWSWIRE) -- A new phase 1 study has begun at the University of Oxford that will investigate the use of a modified vaccinia Ankara (MVA)...
May 07, 2015 16:28 ET | Source: Emergent Biosolutions, Inc.

Emergent BioSolutions Reports First Quarter 2015 Financial Results

GAITHERSBURG, Md., May 7, 2015 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) reported financial results for the quarter ended March 31, 2015. Financial highlights for Q1 2015...
April 30, 2015 07:00 ET | Source: Emergent Biosolutions, Inc.

Emergent BioSolutions Expands Commercial Product Portfolio With FDA Approval of IXINITY, a Recombinant Factor IX Treatment for Hemophilia B

GAITHERSBURG, Md., April 30, 2015 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced that the U.S. Food and Drug Administration (FDA) has approved IXINITY® [coagulation...
April 29, 2015 16:01 ET | Source: Emergent Biosolutions, Inc.

Emergent BioSolutions to Participate in May and June 2015 Investor Conferences

GAITHERSBURG, Md., April 29, 2015 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) announced today that a member of the company's senior management team will participate in the following...
April 22, 2015 16:01 ET | Source: Emergent Biosolutions, Inc.

Emergent BioSolutions Completes Investigation and Resumes BioThrax Manufacturing Activities; Re-Affirms Previous Full-Year 2015 Financial Outlook

Internal investigation completed; implementing targeted corrective and preventive actions Full year 2015 outlook re-affirmed Total revenues of $510-$540 million Net income...